Cardiovascular Devices Market

Global Cardiovascular Devices Market Size, Share, Growth Analysis, By Device(Diagnostic, Monitoring Devices), By Application(Coronary Artery Disease, Cardiac Arrhythmia), By End user(Hospitals, Specialty Clinics) - Industry Forecast 2024-2031

Report ID: SQMIG35E2016 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 91 | Figures: 76

Global Cardiovascular Devices Market News

In July 2021, The Guardian device, the company's flagship item, has undergone its first commercial implantation in the United States, according to Angel Medical Systems, Inc. The recent FDA approval they received was used for this first surgery.

In April 2021, Phoenix Cardiac Devices, Inc. declared that their BACE (Basal Annuloplasty of the Cardio externally) device has a CE Mark. The marketing of BACE in the European Union is aided by this approval.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cardiovascular Devices Market size was valued at USD 17.822 billion in 2019 and is poised to grow from USD 18.8 billion in 2023 to USD 31.1 billion by 2031, growing at a CAGR of 5.5% in the forecast period (2024-2031).

The cardiovascular devices market is relatively fragmented, with a high level of competition. Companies are working on new product launches and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses to increase market share and profitability. 'Abbott Laboratories', 'Boston Scientific Corporation', 'Medtronic, Inc.', 'St. Jude Medical, Inc.', 'Johnson & Johnson', 'Terumo Corporation', 'Edwards Lifesciences Corporation', 'Biotronik SE & Co. KG', 'LivaNova PLC', 'Getinge AB', 'Hill-Rom Holdings, Inc.', 'Koninklijke Philips N.V.', 'Siemens Healthineers AG', 'GE Healthcare', 'Toshiba Corporation', 'Fujifilm Holdings Corporation', 'Hitachi, Ltd.', 'Nihon Kohden Corporation', 'Cardiac Science Corporation', 'Schiller AG'

Rise in the Prevalence of Cardiovascular Diseases to Boost the Global Market

High Demand for Advanced Features in Cardiovascular Devices

On the basis of region, the global cardiovascular devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Cardiovascular Devices Market

Report ID: SQMIG35E2043 | Region: Global | Published Date: February, 2024 | Pages: 219 | Tables: 86 | Figures: 71

Global Rhinoplasty Implants Market
Buy Now GET FREE SAMPLE
Cardiovascular Devices Market

Report ID: UCMIG35E2006 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Home Healthcare Software Market
Buy Now GET FREE SAMPLE
Cardiovascular Devices Market

Report ID: UCMIG35E2017 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Restorative Dentistry Market
Buy Now GET FREE SAMPLE
Cardiovascular Devices Market

Report ID: SQMIG35E2036 | Region: Global | Published Date: February, 2024 | Pages: 157 | Tables: 70 | Figures: 75

Global Dental Laboratories Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Cardiovascular Devices Market

Product ID: SQMIG35E2016

$5,300
BUY NOW GET FREE SAMPLE